Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
3.220
+0.020 (0.63%)
Feb 21, 2025, 4:00 PM EST - Market closed
Elutia Employees
Elutia had 54 employees as of December 31, 2023. The number of employees decreased by 110 or -67.07% compared to the previous year.
Employees
54
Change (1Y)
-110
Growth (1Y)
-67.07%
Revenue / Employee
$458,926
Profits / Employee
-$1,003,741
Market Cap
129.06M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 54 | -110 | -67.07% |
| Dec 31, 2022 | 164 | -12 | -6.82% |
| Dec 31, 2021 | 176 | 13 | 7.98% |
| Dec 31, 2020 | 163 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
ELUT News
- 1 day ago - Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025 - GlobeNewsWire
- 19 days ago - Elutia Announces $15.0 Million Registered Direct Offering - GlobeNewsWire
- 3 months ago - Elutia Inc. (ELUT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30 - GlobeNewsWire
- 5 months ago - Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company's Antibiotic-Eluting BioEnvelope for Implantable Devices - GlobeNewsWire
- 6 months ago - Elutia Celebrates First Year - GlobeNewsWire
- 6 months ago - Elutia Announces First Patient Implant of EluPro™, the World's First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators - GlobeNewsWire
- 6 months ago - Elutia to Participate in Upcoming Investor Conferences - GlobeNewsWire